期刊文献+

骨髓增生异常综合征患者临床特征分析 被引量:5

Analysis of Clinical Features of Patients with Myelodysplastic Syndrome
下载PDF
导出
摘要 目的探讨细胞形态学检查、流式细胞术、细胞遗传学对MDS诊断分型的作用。方法以2016年WHO对MDS诊断分型标准为主要参考,回顾性分析安徽医科大学附属安徽省立医院2013年5月~2017年的12月收治住院的120例成人MDS患者的临床症状、血常规、骨髓细胞学、骨髓病理、免疫表型、细胞遗传学方面的特点。结果 120例MDS患者,根据2016年WHO分类,有2例(1.67%)患者符合MDS伴单系病态造血(MDS-SLD);有27例(22.50%)患者符合MDS伴多系病态造血(MDS-MLD),各有3例(2.50%)和4例(3.33%)患者符合MDS伴环状铁粒幼红细胞伴单系发育异常(MDS-RS-SLD)和MDS伴环状铁粒幼红细胞伴多系发育异常(MDS-RS-MLD),各有34例(28.33%)和43例(35.83%)是MDS-EB-1和MDS-EB-2;2例(1.67%)单纯5q-的MDS;有5例(4.17%)患者MDS未分类。结论骨髓细胞形态学和外周血指标仍是MDS诊断的金标准,临床症状、血常规、骨髓细胞学、骨髓病理、免疫表型、细胞遗传学的综合考虑更有利于MDS的分型诊断,并对治疗、预后判断有重要指导价值。 Objective To investigate the role of cell morphology,flow cytometry and cytogenetics in the diagnosis of MDS.MethodsThe 2016 WHO reference classification criteria for MDS was used as the main reference.Retrospective analysis of clinical symptoms,blood routine,bone marrow cytology,bone marrow pathology,immunophenotype,cytogenetics of 120 adult MDS patients admitted toAnhui Provincial Hospital of Anhui Medical University from May 2013 to December 2017 aspects of the characteristics.Results In120 patients with MDS,according to the 2016 WHO classification,2 patients (1.67% )were eligible for MDS with monosomichematopoiesis (MDS-SLD);27 patients (22.50%)were eligible for MDS with multiline morbid hematopoiesis (MDS-MLD),3 patients(2.50%)and4 patients (3.33%)were eligible for MDS with annular iron granulocytes with monophyletic dysplasia (MDS-RS-SLD)andMDS with annular iron granulocytes Multiple line dysplasia(MDS-RS-MLD),34 cases(28.33%)and 43 cases(35.83%)were MDS-EB-1and MDS -EB -2,respectively;2 cases (1.67% )were simple 5q -MDS;5 patients (4.17% )had unclassified MDS.Conclusion Themorphology of bone marrow cells and peripheral blood markers are still the gold standard for the diagnosis of MDS.The comprehensiveconsideration of clinical symptoms,blood routine,bone marrow cytology,bone marrow pathology,immunophenotype and cytogenetics ismore conducive to the diagnosis of MDS.It has important guiding value for treatment and prognosis.
作者 沈季敏 刘欣 吴金菊 SHEN Ji-min,LIU Xin,WU Jin-ju(Department of Hematology,Provincial Hospital Affiliated to Anhui Medical University/the First Affiliated Hospital,University ofScience and Technology of China,Hefei 230001,Anhui,Chin)
出处 《医学信息》 2018年第18期49-52,共4页 Journal of Medical Information
基金 安徽省自然科学基金项目(编号:1508085MH195)
关键词 骨髓增生异常综合征 WHO分型 临床特征 Myelodysplastic syndrome WHO classification Clinical features
  • 相关文献

参考文献5

二级参考文献43

  • 1万军.骨髓增生异常综合征FAB与WHO分型的比较分析[J].广西医学,2007,29(4):551-552. 被引量:3
  • 2张之南.血液学诊断及疗效标准[M].3版.北京:北京科技出版社,2007:157-163.
  • 3Porwit A. Role of flow cytometry in diagnostics of myelodys- plastic syndromes-beyond the WHO 2008 classification. Semin Diagn Pathol, 2011 ;28(4) :273 -282.
  • 4van de Loosdrecht AA, Alhan C, Bene MC, et al. Standardization of flow cytometry in myelodysplastic syndromes:Report from the first European Leukemia Net working conference on flow cytometry in myelodysplastic syndromes. Haematologica, 2009 ; 94 ( 8 ) : 1124 -1134.
  • 5Della Porta MG, Lanza F, del Vecchio L. Italian Society of Cytometry (GIC). Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia. Cytometry B Clin Cytom, 2011 ;80(4) :201 -211.
  • 6McClintock-Treep SA, Briggs RC, Shults KE, et al. Quantitative assessment of myeloid nuclear differentiation antigen distingui-shes myelodysplastic syndrome from normal bone marrow. Am J Clin Patho1,2011 ; 135 ( 3 ) :380 - 385.
  • 7Cazzola M, Della Portia MG, Malcovati L. Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes. Hematology, 2008( 1 ) :166 - 175.
  • 8Della Porta MG, Malcovati L, Invernizzi R, et al. Flow cytometry evaluation of crythroid dysplasia in patients with myelodysplastic syndrome. Leukemia, 2006;20(4) :549 -555.
  • 9Cazzola M, Invemizzi R, Bergamaschi G, et al. Mitochondrial ferritin expression in erythroid cells from patients with sidcroblastic anemia. Blood,2003 ; 101 (5) : 1996 - 2000.
  • 10Ogata K, Della Porta MG, Malcovati L, et al. Diagnostic utility of flow cytometry in low-grade myclodysplastic syndromes: A prospective validation study. Hacmatologica,2009 ; 94 ( 8 ) : 1066 - 1074.

共引文献47

同被引文献39

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部